142 related articles for article (PubMed ID: 34246382)
21. Allogeneic bone marrow transplantation for AL amyloidosis.
Guillaume B; Straetmans N; Jadoul M; Cosyns JP; Ferrant A
Bone Marrow Transplant; 1997 Nov; 20(10):907-8. PubMed ID: 9404936
[TBL] [Abstract][Full Text] [Related]
22. Unmasking and successful management of light chain deposition disease of kidney in pregnancy: a complex case, mirroring the complex needs of pregnancy with kidney disease in India.
Matthai SM; Jacob S; Devasia AJ; Bindra M; David VG; Varughese S
J Nephrol; 2018 Oct; 31(5):785-791. PubMed ID: 30187379
[TBL] [Abstract][Full Text] [Related]
23. [Randall-type monoclonal immunoglobulin deposition disease: From diagnosis to treatment].
Cohen C; Javaugue V; Joly F; Arnulf B; Fermand JP; Jaccard A; Sirac C; Knebelmann B; Bridoux F; Touchard G
Nephrol Ther; 2016 Jun; 12(3):131-9. PubMed ID: 27117766
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
Ronco P; Plaisier E; Mougenot B; Aucouturier P
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
[TBL] [Abstract][Full Text] [Related]
25. A case of isolated light chain deposition disease in the duodenum.
Kim HJ; Park E; Lee TJ; Do JH; Cha YJ; Lee SJ
J Korean Med Sci; 2012 Feb; 27(2):207-10. PubMed ID: 22323870
[TBL] [Abstract][Full Text] [Related]
26. High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal protein.
Sakakima M; Fujigaki Y; Tsuji T; Fukasawa H; Miyaji T; Naito K; Yamamoto T; Yonemura K; Ohnishi K; Hishida A
Intern Med; 2005 Sep; 44(9):970-4. PubMed ID: 16258214
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation.
Choi SI; Lee EJ; Kang DO; Lee SY; In KH; Kim HK; Park S
Korean J Intern Med; 2016 Nov; 31(6):1181-1183. PubMed ID: 26701227
[No Abstract] [Full Text] [Related]
28. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.
Kaposztas Z; Kahan BD; Katz SM; Van Buren CT; Cherem L
Transplant Proc; 2009 Dec; 41(10):4407-10. PubMed ID: 20005409
[TBL] [Abstract][Full Text] [Related]
29. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
30. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
Herrera GA
Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389
[TBL] [Abstract][Full Text] [Related]
31. Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation.
Jimenez-Zepeda VH; Vajpeyi R; John R; Trudel S
Int J Hematol; 2012 Jul; 96(1):125-31. PubMed ID: 22573235
[TBL] [Abstract][Full Text] [Related]
32. [A case of bronchiectasis due to light chain deposition disease].
Millet F; Gomez E; Hirschi S; Petit I; Chenard MP; Mouget B; Guillaumot A; Chaouat A; Colombat M; Chabot F
Rev Mal Respir; 2019 Apr; 36(4):538-542. PubMed ID: 30686554
[TBL] [Abstract][Full Text] [Related]
33. Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review.
Huang J; Sun C; Su H; Zhang C; Xiong J
Kidney Blood Press Res; 2019; 44(4):858-869. PubMed ID: 31352451
[TBL] [Abstract][Full Text] [Related]
34. Reversible left ventricular dysfunction and acute kidney injury in a patient with nonamyloid light chain deposition disease.
Wadhwa NK; Kamra A; Skopicki HA; Richard S; Miller F; Nord EP
Clin Nephrol; 2012 Dec; 78(6):501-5. PubMed ID: 23164419
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of patients with renal monoclonal immunoglobulin deposition disease.
Kourelis TV; Nasr SH; Dispenzieri A; Kumar SK; Gertz MA; Fervenza FC; Buadi FK; Lacy MQ; Erickson SB; Cosio FG; Kapoor P; Lust JA; Hayman SR; Rajkumar V; Zeldenrust SR; Russell SJ; Dingli D; Lin Y; Gonsalves W; Lorenz EC; Zand L; Kyle RA; Leung N
Am J Hematol; 2016 Nov; 91(11):1123-1128. PubMed ID: 27501122
[TBL] [Abstract][Full Text] [Related]
36. High-dose therapy and autologous transplantation in amyloidosis-AL.
Majolino I; Marcenò R; Pecoraro G; Scimé R; Vasta S; Liberti G; Rizzo A; Indovina A; Caronia F
Haematologica; 1993; 78(1):68-71. PubMed ID: 8098314
[TBL] [Abstract][Full Text] [Related]
37. [Spontaneous splenic rupture in a patient with light-chain deposition disease undergoing autologous peripheral blood stem cell transplantation].
Haji S; Kiyasu J; Tachikawa Y; Toyonaga J; Ikeda M; Tsuda M; Tsukamoto Y; Kozuru M; Yufu Y
Rinsho Ketsueki; 2016 Jun; 57(6):754-9. PubMed ID: 27384856
[TBL] [Abstract][Full Text] [Related]
38. OCULAR MANIFESTATIONS OF MONOCLONAL IMMUNOGLOBULIN LIGHT CHAIN DEPOSITION DISEASE.
Dhrami-Gavazi E; Freund KB; Lee W; Cohen BZ; Seshan SV; Yannuzzi LA
Retin Cases Brief Rep; 2017 Fall; 11(4):310-315. PubMed ID: 27315323
[TBL] [Abstract][Full Text] [Related]
39. Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.
Sanchorawala V; Seldin DC; Magnani B; Skinner M; Wright DG
Bone Marrow Transplant; 2005 Oct; 36(7):597-600. PubMed ID: 16044137
[TBL] [Abstract][Full Text] [Related]
40. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation.
Weichman K; Dember LM; Prokaeva T; Wright DG; Quillen K; Rosenzweig M; Skinner M; Seldin DC; Sanchorawala V
Bone Marrow Transplant; 2006 Sep; 38(5):339-43. PubMed ID: 16862166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
